# Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients

> **NCT00859014** · PHASE1 · COMPLETED · sponsor: **The University of Texas Health Science Center, Houston** · enrollment: 25 (actual)

## Conditions studied

- Ischemic Stroke

## Interventions

- **BIOLOGICAL:** Autologous Bone Marrow Mononuclear Cells

## Key facts

- **NCT ID:** NCT00859014
- **Lead sponsor:** The University of Texas Health Science Center, Houston
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-01
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2015-01-01

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00859014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00859014, "Safety/Feasibility of Autologous Mononuclear Bone Marrow Cells in Stroke Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00859014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*